Zoë Tieges1,2, Terence Quinn3, Lorn MacKenzie4, Daniel Davis5, Graciela Muniz-Terrera6, Alasdair M J MacLullich7, Susan D Shenkin7. 1. Geriatric Medicine, Edinburgh Delirium Research Group, Usher Institute, University of Edinburgh, Edinburgh, Scotland, UK. zoe.tieges@ed.ac.uk. 2. School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, UK. zoe.tieges@ed.ac.uk. 3. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. 4. Academic and Clinical Central Office for Research and Development, University of Edinburgh, Edinburgh, UK. 5. MRC Unit for Lifelong Health and Ageing at University College London, London, UK. 6. Centre for Clinical Brain Sciences and Dementia Prevention, University of Edinburgh, Edinburgh, UK. 7. Geriatric Medicine, Edinburgh Delirium Research Group, Usher Institute, University of Edinburgh, Edinburgh, Scotland, UK.
Abstract
BACKGROUND: Delirium is a heterogeneous syndrome with inattention as the core feature. There is considerable variation in the presence and degree of other symptom domains such as altered arousal, psychotic features and global cognitive dysfunction. Delirium is independently associated with increased mortality, but it is unclear whether individual symptom domains of delirium have prognostic importance. We conducted a systematic review and meta-analysis of studies in hospitalised adults in general settings to identify the relationship between symptom domains of delirium and outcomes. (PROSPERO: CRD42018093935). METHODS: We searched MEDLINE, EMBASE, PsycINFO, CINAHL, clinicaltrials.gov and the Cochrane Central Register of Controlled Trials from inception to November 2019. We included studies of hospitalised adults that reported associations between symptom domains of delirium and 30-day mortality (primary outcome), and other outcomes including mortality at other time points, length of stay, and dementia. Reviewer pairs independently screened articles, extracted data, and assessed risk of bias (Risk of Bias Assessment tool for Non-randomized Studies) and quality of evidence using the Grading of Recommendations, Assessment, Development and Evaluation framework. We performed random-effects meta-analyses stratified by delirium domain where possible. RESULTS: From 7092 citations we included 6 studies (6002 patients, 1112 with delirium). Higher mortality (ranging from in-hospital to follow-up beyond 12 months) was associated with altered arousal (pooled Odds Ratio (OR) 2.80, 95% Confidence Interval (CI) 2.33-3.37; moderate-quality evidence), inattention (pooled OR 2.57, 95% CI 1.74-3.80; low-quality evidence), and in single studies with disorientation, memory deficits and disorganised thoughts. Risk of bias varied across studies but was moderate-to-high overall, mainly due to selection bias, lack of blinding of assessments and unclear risk of selective outcome reporting. We found no studies on the association between psychotic features, visuospatial deficits or affective disturbances in delirium and outcomes, or studies reporting non-mortality outcomes. CONCLUSIONS: Few studies have related symptom domains of delirium to outcomes, but the available evidence suggests that altered arousal and inattention in delirium are associated with higher mortality than normal arousal and attention in people with or without delirium. Measurable symptom domains of delirium may have value in predicting survival and stratifying patients for treatment. We recommend that future delirium studies report outcomes by symptom domain.
BACKGROUND: Delirium is a heterogeneous syndrome with inattention as the core feature. There is considerable variation in the presence and degree of other symptom domains such as altered arousal, psychotic features and global cognitive dysfunction. Delirium is independently associated with increased mortality, but it is unclear whether individual symptom domains of delirium have prognostic importance. We conducted a systematic review and meta-analysis of studies in hospitalised adults in general settings to identify the relationship between symptom domains of delirium and outcomes. (PROSPERO: CRD42018093935). METHODS: We searched MEDLINE, EMBASE, PsycINFO, CINAHL, clinicaltrials.gov and the Cochrane Central Register of Controlled Trials from inception to November 2019. We included studies of hospitalised adults that reported associations between symptom domains of delirium and 30-day mortality (primary outcome), and other outcomes including mortality at other time points, length of stay, and dementia. Reviewer pairs independently screened articles, extracted data, and assessed risk of bias (Risk of Bias Assessment tool for Non-randomized Studies) and quality of evidence using the Grading of Recommendations, Assessment, Development and Evaluation framework. We performed random-effects meta-analyses stratified by delirium domain where possible. RESULTS: From 7092 citations we included 6 studies (6002 patients, 1112 with delirium). Higher mortality (ranging from in-hospital to follow-up beyond 12 months) was associated with altered arousal (pooled Odds Ratio (OR) 2.80, 95% Confidence Interval (CI) 2.33-3.37; moderate-quality evidence), inattention (pooled OR 2.57, 95% CI 1.74-3.80; low-quality evidence), and in single studies with disorientation, memory deficits and disorganised thoughts. Risk of bias varied across studies but was moderate-to-high overall, mainly due to selection bias, lack of blinding of assessments and unclear risk of selective outcome reporting. We found no studies on the association between psychotic features, visuospatial deficits or affective disturbances in delirium and outcomes, or studies reporting non-mortality outcomes. CONCLUSIONS: Few studies have related symptom domains of delirium to outcomes, but the available evidence suggests that altered arousal and inattention in delirium are associated with higher mortality than normal arousal and attention in people with or without delirium. Measurable symptom domains of delirium may have value in predicting survival and stratifying patients for treatment. We recommend that future delirium studies report outcomes by symptom domain.
Authors: Jin H Han; Eduard E Vasilevskis; Ayumi Shintani; Amy J Graves; John F Schnelle; Robert S Dittus; James S Powers; Amanda Wilson; Alan B Storrow; E Wesley Ely Journal: J Hosp Med Date: 2014-10-29 Impact factor: 2.960
Authors: Edward R Marcantonio; Long H Ngo; Margaret O'Connor; Richard N Jones; Paul K Crane; Eran D Metzger; Sharon K Inouye Journal: Ann Intern Med Date: 2014-10-21 Impact factor: 25.391
Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher Journal: BMJ Date: 2009-07-21
Authors: Clare Langan; Deep P Sarode; Tom C Russ; Susan D Shenkin; Alan Carson; Alasdair M J Maclullich Journal: Psychogeriatrics Date: 2017-01-27 Impact factor: 2.440
Authors: Thiago Junqueira Avelino-Silva; Flavia Campora; Jose Antonio Esper Curiati; Wilson Jacob-Filho Journal: PLoS One Date: 2018-01-30 Impact factor: 3.240
Authors: Franchesca Arias; Margarita Alegria; Amy J Kind; Richard N Jones; Thomas G Travison; Edward R Marcantonio; Eva M Schmitt; Tamara G Fong; Sharon K Inouye Journal: J Am Geriatr Soc Date: 2021-10-25 Impact factor: 5.562
Authors: Alex Tsui; Samuel D Searle; Helen Bowden; Katrin Hoffmann; Joanne Hornby; Arley Goslett; Maryse Weston-Clarke; Lee Hamill Howes; Rebecca Street; Rachel Perera; Kayvon Taee; Christoph Kustermann; Petronella Chitalu; Benjamin Razavi; Francesco Magni; Devajit Das; Sung Kim; Nish Chaturvedi; Elizabeth L Sampson; Kenneth Rockwood; Colm Cunningham; E Wesley Ely; Sarah J Richardson; Carol Brayne; Graciela Muniz Terrera; Zoё Tieges; Alasdair MacLullich; Daniel Davis Journal: Lancet Healthy Longev Date: 2022-04
Authors: Ryan A Tesh; Haoqi Sun; Jin Jing; Mike Westmeijer; Anudeepthi Neelagiri; Subapriya Rajan; Parimala V Krishnamurthy; Pooja Sikka; Syed A Quadri; Michael J Leone; Luis Paixao; Ezhil Panneerselvam; Christine Eckhardt; Aaron F Struck; Peter W Kaplan; Oluwaseun Akeju; Daniel Jones; Eyal Y Kimchi; M Brandon Westover Journal: Crit Care Explor Date: 2022-01-18
Authors: Antara Banerji; Jamie W Sleigh; Logan J Voss; Paul S Garcia; Amy L Gaskell Journal: Front Aging Neurosci Date: 2022-10-04 Impact factor: 5.702